Literature DB >> 17223359

Expression, purification, and characterization of arginine deiminase from Lactococcus lactis ssp. lactis ATCC 7962 in Escherichia coli BL21.

Jong-Eun Kim1, Do-Won Jeong, Hyong Joo Lee.   

Abstract

The arcA gene that encodes arginine deiminase (ADI, EC 3.5.3.6)--a key enzyme of the ADI pathway--was cloned from Lactococcus lactis ssp. lactis ATCC 7962. The deduced amino acid sequence of the arcA gene showed high homology with the arcA gene from Lactobacillus plantarum (99%) and from Lactobacillus sakei (60%), respectively. The arcA gene from Lc. lactis spp. lactis ATCC 7962 was expressed in soluble fraction of recombinant Escherichia coli BL21. ADI produced from Lc. lactis spp. lactis ATCC 7962 (LADI) in E. coli BL21 (DE3) was purified using sequential Q-Sepharose anion exchange and Sephacryl S-200 gel filtration column chromatography. The final yield of LADI in the purification procedure was 63.5%, and the specific activity was 140.27 U/mg. The presence of purified LADI was confirmed by N-terminal sequencing and determination of the molecular mass. The LADI had a molecular mass of about 140 kDa, and comprised a homotrimer of 46 kDa in the native condition. LADI exhibited only 35% amino acid sequence homology with ADI from Mycoplasma arginini. However, LADI shared a similar three dimensional structure. The K(M) and V(max) values for arginine were 8.67+/-0.045 mM (mean+/-SD) and 344.83+/-1.79 micromol/min/mg, respectively, and the optimum temperature and pH for the production of LADI were 60 degrees C and 7.2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17223359     DOI: 10.1016/j.pep.2006.12.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

1.  In silico and in vitro analysis of arginine deiminase from Pseudomonas furukawaii as a potential anticancer enzyme.

Authors:  Rakhi Dhankhar; Anubhuti Kawatra; Vatika Gupta; Aparajita Mohanty; Pooja Gulati
Journal:  3 Biotech       Date:  2022-08-12       Impact factor: 2.893

2.  Expression of arginine deiminase from Pseudomonas plecoglossicida CGMCC2039 in Escherichia coli and its anti-tumor activity.

Authors:  Ye Ni; Zhenwei Li; Zhihao Sun; Pu Zheng; Yongmei Liu; Leilei Zhu; Ulrich Schwaneberg
Journal:  Curr Microbiol       Date:  2009-03-12       Impact factor: 2.188

3.  Arginine deaminase from Pseudomonas aeruginosa PS2: purification, biochemical characterization and in-vitro evaluation of anticancer activity.

Authors:  Kiran Bala; Islam Husain; Anjana Sharma
Journal:  3 Biotech       Date:  2020-05-02       Impact factor: 2.406

4.  Application of response surface methodology for optimizing arginine deiminase production medium for Enterococcus faecium sp. GR7.

Authors:  Baljinder Kaur; Rajinder Kaur
Journal:  ScientificWorldJournal       Date:  2013-12-17

5.  Cultivation to improve in vivo solubility of overexpressed arginine deiminases in Escherichia coli and the enzyme characteristics.

Authors:  Ying Wang; Yue-Zhong Li
Journal:  BMC Biotechnol       Date:  2014-06-07       Impact factor: 2.563

6.  Dietary Probiotic Effect of Lactococcus lactis WFLU12 on Low-Molecular-Weight Metabolites and Growth of Olive Flounder (Paralichythys olivaceus).

Authors:  Thanh Luan Nguyen; Won-Kyong Chun; Ahran Kim; Nameun Kim; Heyong Jin Roh; Yoonhang Lee; Myunggi Yi; Suhkmann Kim; Chan-Il Park; Do-Hyung Kim
Journal:  Front Microbiol       Date:  2018-09-05       Impact factor: 5.640

7.  Enzymology of the pathway for ATP production by arginine breakdown.

Authors:  Tjeerd Pols; Shubham Singh; Cecile Deelman-Driessen; Bauke F Gaastra; Bert Poolman
Journal:  FEBS J       Date:  2020-05-05       Impact factor: 5.542

8.  Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer.

Authors:  Sai-Fung Chung; Chi-Fai Kim; Sui-Yi Kwok; Suet-Ying Tam; Yu Wai Chen; Hiu-Chi Chong; Siu-Lun Leung; Pui-Kin So; Kwok-Yin Wong; Yun-Chung Leung; Wai-Hung Lo
Journal:  Int J Mol Sci       Date:  2020-06-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.